Clinical and pharmacological significance of α2-adrenoceptor polymorphisms in cardiovascular diseases
Authors:
- Antonios ManolisAMAntonios Manolis
- Mika ScheininMSMika Scheinin
- Hervé ParisHPHervé Paris
- 1 December 2004
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 97 (3) , 367-372
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Using green fluorescent proteins to study G-protein-coupled receptor localization and traffickingTrends in Pharmacological Sciences, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Human adrenoceptor polymorphisms: evolving recognition of clinical importanceTrends in Pharmacological Sciences, 1999
- G protein-coupled receptor adaptation mechanismsSeminars in Cell & Developmental Biology, 1998
- Gene targeting — homing in on α2-adrenoceptor-subtype functionTrends in Pharmacological Sciences, 1997
- Defects in G Protein-Coupled Signal Transduction in Human DiseaseAnnual Review of Physiology, 1996
- α2 Adrenergic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells Activate Differentially Mitogen-activated Protein Kinase by a p21 Independent PathwayJournal of Biological Chemistry, 1995
- A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious pubertyNature, 1993
- Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomasNature, 1993
- A Point Mutation of the α 2 -Adrenoceptor that Blocks Coupling to Potassium but not Calcium CurrentsScience, 1992